Free Trial

IGM Biosciences (IGMS) Insider Trading & Ownership

IGM Biosciences logo
$9.29 +0.40 (+4.50%)
(As of 03:32 PM ET)

IGM Biosciences (NASDAQ:IGMS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
57.00%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$5.57 M
Number Of
Insiders Selling
(Last 12 Months)
6
Amount Of
Insider Selling
(Last 12 Months)
$572,280.98
Get IGMS Insider Trade Alerts

Want to know when executives and insiders are buying or selling IGM Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

IGMS Insider Buying and Selling by Quarter

IGM Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2024Fred SchwarzerCEOSell3,946$11.54$45,536.84  
9/13/2024Misbah TahirCFOSell1,487$11.54$17,159.98  
9/13/2024Steven WeberInsiderSell469$11.54$5,412.26  
7/25/2024Julie HambletonDirectorSell15,132$14.00$211,848.00  
6/14/2024Fred SchwarzerCEOSell4,164$7.58$31,563.12  
6/14/2024Misbah TahirCFOSell1,570$7.58$11,900.60  
Trump won. Buy this coin now. (Ad)

Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.

6/14/2024Steven WeberInsiderSell495$7.58$3,752.10  
3/28/2024Bros. Advisors Lp BakerDirectorBuy97,473$9.62$937,690.26  
3/26/2024Bros. Advisors Lp BakerDirectorBuy270,000$8.26$2,230,200.00  
3/13/2024Fred SchwarzerCEOSell4,765$9.88$47,078.20  
3/13/2024Misbah TahirCFOSell2,897$9.88$28,622.36  
3/13/2024Steven WeberInsiderSell529$9.88$5,226.52  
12/15/2023Bros. Advisors Lp BakerDirectorBuy288,007$6.55$1,886,445.85  
12/13/2023Bros. Advisors Lp BakerDirectorBuy87,316$5.96$520,403.36  
12/13/2023Bruce KeytInsiderSell7,574$5.78$43,777.72  
12/13/2023Fred SchwarzerCEOSell17,576$5.78$101,589.28  
11/29/2023Chris H TakimotoInsiderSell1,180$6.21$7,327.80  
11/27/2023Bruce KeytInsiderSell933$5.06$4,720.98  
11/27/2023Misbah TahirCFOSell1,337$5.06$6,765.22  
(Data available from 1/1/2013 forward)

IGMS Insider Trading Activity - Frequently Asked Questions

The list of insiders at IGM Biosciences includes Bros. Advisors Lp Baker, Bruce Keyt, Chris H Takimoto, Fred Schwarzer, George Gauthier, Jakob Haldor Topsoe, Julie Hambleton, M Kathleen Behrens, Michael D Loberg, Misbah Tahir, and Steven Weber. Learn more on insiders at IGMS.

57.00% of IGM Biosciences stock is owned by insiders. Learn more on IGMS's insider holdings.

The following insiders have purchased IGMS shares in the last 24 months: Bros. Advisors Lp Baker ($5,574,739.47), Jakob Haldor Topsoe ($31,850.00), and M Kathleen Behrens ($900,000.00).

Insiders have purchased a total of 858,796 IGMS shares in the last 24 months for a total of $6,506,589.47 bought.

The following insiders have sold IGMS shares in the last 24 months: Bruce Keyt ($48,498.70), Chris H Takimoto ($159,002.13), Fred Schwarzer ($460,531.06), George Gauthier ($28,031.37), Julie Hambleton ($211,848.00), Misbah Tahir ($183,799.50), and Steven Weber ($14,390.88).

Insiders have sold a total of 93,770 IGM Biosciences shares in the last 24 months for a total of $1,106,101.64 sold.

IGM Biosciences Key Executives

  • Mr. Fred M. Schwarzer J.D. (Age 71)
    CEO, President & Director
    Compensation: $977.66k
  • Dr. Bruce A. Keyt Ph.D. (Age 70)
    Chief Scientific Officer
    Compensation: $692.95k
  • Dr. Chris H. Takimoto FACP (Age 65)
    M.D., Ph.D., Chief Medical Officer
    Compensation: $684.95k
  • Mr. Misbah Tahir (Age 48)
    Chief Financial Officer
    Compensation: $957.6k
    2 recent trades
  • Mr. TS Harigopal
    Senior Vice President of Group Operations
  • Mr. Steven Weber (Age 48)
    Senior VP, Corporate Controller & Principal Accounting Officer
    2 recent trades
  • Mr. Paul C. Graffagnino
    Senior Vice President of Legal Affairs
  • Ms. Suzette Tauber (Age 60)
    Chief Human Resources Officer
  • Dr. Angus M. Sinclair Ph.D.
    Senior Vice President of Immuno-Oncology
  • Dr. Lisa L. Decker Ph.D. (Age 54)
    Chief Business Officer
    Compensation: $528.18k


This page (NASDAQ:IGMS) was last updated on 11/25/2024 by MarketBeat.com Staff
From Our Partners